The European Medicines Agency Discovers the Geriatric Patient

By Baeyens JP  

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 849-851

Adis International

Access to resources Recommend Favorite

Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance

By Permanand Govin   Mossialos Elias   McKee Martin  

Clinical Medicine, Vol. 6, Iss. 1, 2006-01 ,pp. : 87-90

Royal College Of Physicians

Access to resources Recommend Favorite

Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval

By Apolone G.  

PharmacoEconomics, Vol. 19, Iss. 2, 2001-01 ,pp. : 187-195

Adis International

Access to resources Recommend Favorite

Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Conclusions of the Drug Information Association (DIA)/European Medicines Agency (EMEA) Workshop, October 27-28, 2003 in London, UK

By Peter Kasper  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 221-223

Adis International

Access to resources Recommend Favorite

The European Medicines Agency has announced they will be making important changes.

By  

Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite